Skip to main content
Clinical Trials/JPRN-UMIN000014065
JPRN-UMIN000014065
Completed
未知

A study to examine cerebrospinal fluid transitivity and efficacy of afatinib in carcinomatous meningitis patients with non-small cell lung cancer patients harboring EGFR mutation. - A cerebrospinal fluid transitivity identification test of afatinib

Kinki-Chuo Chest Medical Center0 sites10 target enrollmentMay 26, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
carcinomatous meningitis patients with NSCLC harboring EGFR mutation
Sponsor
Kinki-Chuo Chest Medical Center
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 26, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kinki-Chuo Chest Medical Center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. over Grade 2 of diarrhea, a severe gastrointestinal disorder 2\. Interstitial lung disease 3\. diagnose of malignancy in 5 years 4\. Angina and myocardial infarction within six months, heart disorder, severe arrhythmia 5\. pleural effusion or ascites which need treatment 6\. uncontrolled complications 7\. Serious drug allergy history 8\. Cannot promise contraception 9\. No pregnancy, during nursing 10\. A chief physician decide not eligible

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
An investigation on spinal fluid in patients with sciatica-type or nerve-type pain of the lower limbeuropathic lower limb painNervous System Diseases
ISRCTN34007592Trinity Translational Medicine Institute12
Active, not recruiting
Phase 1
An open-labelled study of the cerebrospinal fluid pharmacokinetics of intravenous Kineret® in patients with subarachnoid haemorrhage - IL-1RA in SAH PK STUDY 2This is a pharmacokinetic study in patients who have had a Subarachnoid Haemorrhage and who have had an external ventricular drain inserted for clinical management reasons, must usually for the treatment of hydrocephalus.MedDRA version: 9.1 Level: LLT Classification code 10042316 Term: Subarachnoid haemorrhageMedDRA version: 9.1 Level: LLT Classification code 10052947 Term: Ventricular drainageMedDRA version: 9.1 Level: LLT Classification code 10020508 Term: Hydrocephalus
EUCTR2007-002337-36-GBSalford Royal NHS Foundation Trust100
Not yet recruiting
Not Applicable
To see effect of shunt surgery on optic nerve sheath diameter by ultrasound of eyeHealth Condition 1: G912- (Idiopathic) normal pressure hydrocephalusHealth Condition 2: G910- Communicating hydrocephalusHealth Condition 3: G914- Hydrocephalus in diseases classified elsewhereHealth Condition 4: G911- Obstructive hydrocephalusHealth Condition 5: G918- Other hydrocephalusHealth Condition 6: G913- Post-traumatic hydrocephalus, unspecified
CTRI/2018/11/016314DR Ram Manohar Lohia Institute Of Medical Sciences
Completed
Not Applicable
The study analyzing blood and cerebrospinal fluids from the patients with early onset Alzheimer disease to discover causative factors and biomarkersDiseases of the nervous system
KCT0000847Soon Chun Hyang University Hospital Bucheon516
Recruiting
Not Applicable
Assessment of Cerebrospinal Fluid Flow Related Disorders Using a Phase-contrast Magnetic Resonance Imaging Technique.Cerebrospinal Fluid
NCT03656016Assiut University87